Go back to:   
 
 

The Council on Menopause Management
Video: Clinical Challenges and Quality of Life Issues

Release Date: August 3, 2009
Expiration Date: August 2, 2010

To Play Video:
Please scroll through this page to read all the disclosures and important information. Then click the Play Video button at the bottom of the page to continue.
 
 

The 2009 Council on Menopause Management

The 2009 Menopause Council convened in Chicago to objectively discuss the most current research and thinking regarding optimal clinical management of several conditions and health issues in menopausal women including: Cardiovascular Health, Bone Health, Breast Cancer, Quality of Life and Sexual Dysfunction, Thromboembolism, and Cognitive Function and Dementia.

This video presentation will cover key clinical issues on Quality of Life and Sexual Dysfunction and the council's consensus recommendations for clinicians in patient management.

   
  Follow us on Twitter  

 
  Signup for our iphone app
 
   

Disclosures and Important Information


Sponsored by the Duke University School of Medicine

In collaboration with

Supported by an educational grant from Wyeth

Release Date: August 3, 2009

Expiration Date: August 2, 2010

Estimated time to complete this activity: 1.0 hour

Accreditation Statement

The Duke University School of Medicine is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.

Credit Designation Statement

The Duke University School of Medicine designates this educational activity for a maximum of 1.0 AMA PRA Category 1 Credit™. Physicians should only claim credit commensurate with the extent of their participation in the activity.

This activity has been reviewed and is acceptable for up to 1.0 Prescribed credits by the American Academy of Family Physicians. AAFP accreditation begins 7/15/09. Term of approval is for one year from this date, with option for yearly renewal.

Course Co-chairs and Principal Faculty

Charles B. Hammond, MD (Co-chair)
E. C. Hamblen Professor
Chair Emeritus, Department of Obstetrics and Gynecology
Reproductive Endocrinology and Fertility
Duke University Medical Center
Durham, NC

Michelle P. Warren, MD (Co-chair)
Medical Director, Center for Menopause, Hormonal
Disorders and Women's Health
Department of Obstetrics and Gynecology
Columbia University Medical Center
New York, NY

David F. Archer, MD
Professor, Obstetrics and Gynecology
Director, CONRAD Clinical Research Center
Eastern Virginia Medical School
The Jones Institute of Reproductive Medicine
Norfolk, VA

Target Audience

This activity is intended for gynecologists, family practitioners, internists, and other practitioners who care for menopausal women.

Prerequisites

There are no prerequisites.

Statement of Need

Menopause-related vasomotor symptoms can diminish menopausal women's quality of life. With so many different types of interventions available for the treatment of vasomotor symptoms, women should be active participants in the treatment decision-making process. This educational activity has been designed to facilitate application of the latest research and guidelines to help clinicians improve counseling, management, treatment, and care of menopausal women with the ultimate goal of increasing their longevity and quality of life.

Objectives

After completing this activity, you should be able to:

  • Describe the impact of menopause on life functions and quality of life
  • Discuss the effects of hormone therapy (HT) on menopause symptoms, hot flashes, vaginal atrophy, sleep disturbance, mood depression, and sexuality
  • Identify the effects of central nervous system agents; SSRI, SSNRI, and gabapentin on hot flashes, mood, and depression
  • Discuss the use of alternative agents for the management of menopause therapy

Method of Participation

This internet-based activity takes approximately 1 hour to complete. You should review the CME information (objectives, disclosures, etc) and then watch the video, answer the multiple-choice post-test and complete an evaluation form online. Once completed, you will be able to save your certificate to your own computer and print it on your own printer.

Resolution of Conflicts of Interest

In accordance with the ACCME Standards for Commercial Support of CME, the Duke University School of Medicine implemented mechanisms, prior to the planning and implementation of this CME activity, to identify and resolve conflicts of interest for all individuals in a position to control content of this CME activity.

Staff and Content Validation Reviewer Disclosure

The staff involved with this activity and any content validation reviewers of this activity have reported no relevant financial relationships with commercial interests.

Planning Committee/Faculty Disclosure

The following speakers and/or planning committee members have indicated they have no relationship(s) with industry to disclose relative to the content of this CME activity: Brian McDonough, MD; Carolyn Darrow, MPH; Lillie Chen; and Shelly Minutillo.

The following speakers and/or planning committee members have indicated that they have relationship(s) with industry to disclose:

Charles B. Hammond, MD Board Member: Bayer Pharmaceuticals
Michelle P. Warren, MD Consultant: Barr Laboratories (Duramed), Bradley Pharmaceuticals, Ferring, QuatRx, Warner Chilcott
Speakers Bureau: Eli Lilly & Co., Merck & Co., Novartis, Novo Nordisk, Upsher Smith, Warner Chilcott, Wyeth Pharmaceuticals Inc.
Grant/Research Support: Novartis, Solvay, Wyeth Pharmaceuticals, Inc.
Advisory Board Member: Wyeth Pharmaceuticals, Inc.
Wyeth-Ayerst Professor of Woman's Health: Wyeth Pharmaceuticals, Inc.
David F. Archer, MD Consultant: Agile Therapeutics, Inc., Bayer Healthcare, Radius Pharmaceuticals, Inc., Schering-Plough Organon, Xanodyne Pharmaceuticals Inc.
Grants/Research Support: Bayer Healthcare, Schering-Plough Organon, Xanodyne Pharmaceuticals Inc., Wyeth Pharmaceuticals Inc.
Speakers Bureau: Organon, Schering-Plough, Wyeth Pharmaceuticals, Inc.
Stock Options: Agile Therapeutics, Inc.

Unapproved Use Disclosure

The Duke University School of Medicine requires CME faculty (speakers) to disclose to attendees when products or procedures being discussed are off-label, unlabeled, experimental, and/or investigational (not FDA approved); and any limitations on the information that is presented, such as data that are preliminary or that represent ongoing research, interim analyses, and/or unsupported opinion. Faculty will discuss information about pharmaceutical agents that is outside of U.S. Food and Drug Administration approved labeling. This information is intended solely for continuing medical education and is not intended to promote off-label use of these medications. If you have questions, contact the medical affairs department of the manufacturer for the most recent prescribing information.

The following off-label use(s) are discussed in this CME activity:

  • Use of testosterone gel in women
  • Use of vaginal estrogens with recurrent UTI

Disclaimer

The information provided in this CME activity is for continuing education purposes only and is not meant to substitute for the independent medical judgment of a healthcare provider relative to diagnostic and treatment options of a specific patient’s medical condition. The opinions and recommendations expressed by faculty and other experts whose input is included in this activity are their own.

The MedCases Web site does not define a standard of care, nor is it intended to dictate an exclusive course of management. Cases are provided for informational and educational purposes only and are not intended as medical advice. This information should not substitute for a visit or consultation with a health care provider.

Privacy Statement

MedCases is committed to maintaining site visitor's rights to privacy and confidentiality of personal information. Personal information about site visitors and specific visitor's access and navigation, and information volunteered by site visitors, such as survey information and site registration information, may be used by MedCases to improve the site but will not be shared with or sold to other organizations for commercial purposes without the site visitor's express permission.
Please click here to read MedCases' detailed privacy policy and other terms of using this web site.

Copyright Information

Copyright © 2009 MedCases, LLC. All rights reserved.

Technical Questions:

MedCases
4365 US Highway 1, Suite 207
Princeton, NJ 08540
Phone (609) 454-0680
Fax (609) 951-0112
cme@medcases.com

CME Questions:

Duke University School of Medicine
3100 Tower Boulevard, Suite 1300
Durham, NC 27707
Phone (919) 401-1200
Fax (919) 401-1213
cme@mc.duke.edu

Hardware/Software Requirements and Technical Assistance

This Web-based CME activity is best experienced using a current generation browser, such as Internet Explorer 5.5 or higher. This Web site requires that JavaScript and session cookies be enabled. In addition, you will require the Adobe Flash Player plugin to view the video.

Detailed Requirements:

  • 128 MB RAM
  • Windows 98 or newer
  • Adobe Flash Player 8 minimum needed
  • Audio playback with speakers for programs that have video content
  • Internet Explorer 5.5 or higher or Mozilla Firefox 1.0 or higher or Apple Safari
  • 1024 x 768 resolution
  • Broadband connection highly recommended

More information about the software described above is available at the links below:

If you need assistance, please use the help link above to contact technical support.


Confirmation

By clicking the Play Video button below, you are confirming that you have read all the disclosures and important information on this page. Once you have played the video, you may answer the multiple-choice post-test and complete an evaluation form to obtain your certificate.

   
 
   

 
 
Please enter your e-mail address: